| Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies A Mandal, R Bisht, ID Rupenthal, AK Mitra Journal of Controlled Release 248, 96-116, 2017 | 448 | 2017 |
| Injectable implants for the sustained release of protein and peptide drugs P Agarwal, ID Rupenthal Drug discovery today 18 (7-8), 337-349, 2013 | 217 | 2013 |
| Overcoming ocular drug delivery barriers through the use of physical forces D Huang, YS Chen, ID Rupenthal Advanced drug delivery reviews 126, 96-112, 2018 | 200 | 2018 |
| Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release ID Rupenthal, CR Green, RG Alany International journal of pharmaceutics 411 (1-2), 69-77, 2011 | 186 | 2011 |
| Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems MN Yasin, D Svirskis, A Seyfoddin, ID Rupenthal Journal of Controlled Release 196, 208-221, 2014 | 167 | 2014 |
| Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases R Bisht, A Mandal, JK Jaiswal, ID Rupenthal Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 10 (2 …, 2018 | 143 | 2018 |
| Connexin43 in retinal injury and disease HV Danesh-Meyer, J Zhang, ML Acosta, ID Rupenthal, CR Green Progress in retinal and eye research 51, 41-68, 2016 | 128 | 2016 |
| Dendrimers for gene delivery–a potential approach for ocular therapy? SP Chaplot, ID Rupenthal Journal of Pharmacy and Pharmacology 66 (4), 542-556, 2014 | 123 | 2014 |
| The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release OO Mugisho, CR Green, DT Kho, J Zhang, ES Graham, ML Acosta, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1862 (3), 385-393, 2018 | 119 | 2018 |
| Formulation considerations for the management of dry eye disease P Agarwal, JP Craig, ID Rupenthal Pharmaceutics 13 (2), 207, 2021 | 102 | 2021 |
| In vitro and ex vivo corneal penetration and absorption models P Agarwal, ID Rupenthal Drug delivery and translational research 6, 634-647, 2016 | 98 | 2016 |
| Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery to the retina D Huang, YS Chen, ID Rupenthal Molecular pharmaceutics 14 (2), 533-545, 2017 | 92 | 2017 |
| Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia D Huang, YS Chen, CR Green, ID Rupenthal Biomaterials 168, 10-23, 2018 | 88 | 2018 |
| Tonabersat prevents inflammatory damage in the central nervous system by blocking connexin43 hemichannels Y Kim, JM Griffin, MNM Nor, J Zhang, PS Freestone, HV Danesh-Meyer, ... Neurotherapeutics 14, 1148-1165, 2017 | 85 | 2017 |
| Sustained intravitreal delivery of connexin43 mimetic peptide by poly (D, L-lactide-co-glycolide) acid micro-and nanoparticles–closing the gap in retinal ischaemia YS Chen, CR Green, K Wang, HV Danesh-Meyer, ID Rupenthal European Journal of Pharmaceutics and Biopharmaceutics 95, 378-386, 2015 | 81 | 2015 |
| Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study ID Rupenthal, CR Green, RG Alany International journal of pharmaceutics 411 (1-2), 78-85, 2011 | 74 | 2011 |
| Nanoparticle cross-linked collagen shields for sustained delivery of pilocarpine hydrochloride Y Agban, J Lian, S Prabakar, A Seyfoddin, ID Rupenthal International Journal of Pharmaceutics 501 (1-2), 96-101, 2016 | 73 | 2016 |
| Role of gap junctions in chronic pain A Wu, CR Green, ID Rupenthal, G Moalem‐Taylor Journal of neuroscience research 90 (2), 337-345, 2012 | 72 | 2012 |
| Improved corneal wound healing through modulation of gap junction communication using connexin43-specific antisense oligodeoxynucleotides CN Grupcheva, WT Laux, ID Rupenthal, J McGhee, CNJ McGhee, ... Investigative ophthalmology & visual science 53 (3), 1130-1138, 2012 | 71 | 2012 |
| Modern approaches to the ocular delivery of cyclosporine A P Agarwal, ID Rupenthal Drug discovery today 21 (6), 977-988, 2016 | 70 | 2016 |
Monica L AcostaSchool of Optometry and Vision Science, The University of AucklandVerificeret mail på auckland.ac.nz